Chiral Technologies, Inc. provides products and custom services for resolution of racemic compounds by enantioselective chromatography.
Company Description
Chiral Technologies, Inc. provides products and custom services for resolution of racemic compounds by enantioselective chromatography. The products comprise high-performance liquid chromatography (HPLC) and supercritical fluid chromatography (SFC) columns for analytical, semi-preparative, and preparative enantioselective resolutions, as well as bulk chiral stationary phases, including the innovative immobilized phases CHIRALPAK® IA™, IB™, and IC™. Services range from method development through custom separation solutions for the purification of milligram to multi-kilogram quantities. In addition, process development and pilot studies are offered for projects outsourced for late-stage clinical development. The company is a wholly-owned subsidiary of the Japanese fine chemical producer, Daicel Chemical Industries, Ltd.
Markets Served
Chiral Technologies, the worldwide market leader in enantioselective chromatography, serves the pharmaceutical, agrochemical, and life science industries. Our HPLC and SFC columns are used by pharmaceutical researchers to aid both drug discovery and process development efforts. Custom separation services provide the fastest route from early-stage clinical drug development to market. Our CSPs, including the innovative immobilized phases, play a vital role in the commercial development and manufacture of single-enantiomer products.
Major Products/Services
Industry-standard Daicel columns:
Protein-based chiral columns:
Custom separations:
Facilities
Chiral Technologies' headquarters, including a state-of-the-art technical center, is located in West Chester, Pennsylvania. Fully staffed and equipped technical centers are also located in Strasbourg, France (Chiral Technologies Europe) and at Daicel manufacturing plants in Japan.
Chiral Technologies, Inc.
800 North Five Points Road, West Chester, PA 19380
TELEPHONE
800-6CHIRAL (800-624-4725)
(610) 594-2100
FAX
(610) 594-2325
WEB SITE
NUMBER OF EMPLOYEES
30
YEAR FOUNDED
1990
Targeted Blood Lipidomics of Colorectal Cancer: An HTC-18 Interview with Jef Focant
July 26th 2024At HTC-18 in Leuven, Executive Editor of LCGC International, Alasdair Matheson, spoke to Jef Focant from the University of Liege about his talk entitled, “Targeted Blood Lipidomics of Colorectal Cancer."
Carol Robinson Awarded 2024 Lifetime Achievement European Inventor Award
July 24th 2024Carol Robinson of the University of Oxford has received the European Inventor Award 2024 for Lifetime Achievement from the European Patent Office for her work bringing mass spectrometry to structural biology.